Sterile Injectable Contract Manufacturing Market: By Product Type (Small Volume Products, Large Volume Products, Suspensions, Lyophilized Products, Others), By Service Type (Formulation, Analytical Services, Packaging, Others), By Drug Type (Cytokines, Monoclonal Antibodies, Vaccines, Insulin, Peptide Hormones, Antibiotics, Others), By Therapeutic Area (Diabetes, Cancer, Infectious Diseases, Neurological Diseases, Cardiovascular Diseases, Musculoskeletal Diseases, Others) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Sterile Injectable Contract Manufacturing Market size was valued at USD 24.4 billion in 2023 and is expected to grow at a CAGR of 8.5% from 2024-2030. Sterile injectable contract manufacturing refers to the outsourcing of the production of sterile injectable pharmaceutical products to specialized manufacturing facilities, commonly known as contract manufacturing organizations (CMOs) or contract development and manufacturing organizations (CDMOs). Sterile injectable contract manufacturing encompasses various stages, including formulating, maintaining sterility, filling, quality testing, and adhering to regulatory requirements. The contracted manufacturer is accountable for guaranteeing that the final products satisfy the necessary standards for quality, safety, and effectiveness prior to their distribution to the market. Specialized expertise and facilities play a pivotal role in driving the growth of the sterile injectable contract manufacturing market. The production of sterile injectable pharmaceuticals requires stringent aseptic processes, advanced technologies, and specialized equipment to ensure product safety and efficacy.

Contract manufacturing organizations (CMOs) equipped with state-of-the-art facilities and knowledgeable personnel possess the technical know-how to formulate, manufacture, and package sterile injectables while adhering to the highest quality and regulatory standards. Pharmaceutical companies recognize the complexities involved in sterile production and seek CMOs with proven expertise in maintaining strict sterility, reducing contamination risks, and ensuring consistent product quality. Moreover, cost-efficiency serves as a significant driving factor in propelling the growth of the sterile injectable contract manufacturing market. Establishing and maintaining sterile manufacturing facilities can involve substantial capital investments and ongoing operational costs. Pharmaceutical companies recognize the financial advantages of outsourcing sterile injectable production to specialized contract manufacturing organizations (CMOs). By leveraging the existing state-of-the-art facilities and expertise of CMOs, pharmaceutical companies can avoid the capital expenditures associated with building and equipping sterile facilities. However, maintaining consistent product quality and ensuring proper adherence to regulatory standards can be challenging when manufacturing is outsourced. These strict regulatory requirements pose a challenge to the growth of the market. Meanwhile, rising government investments in advanced technologies offer several opportunities for the growth of the sterile injectable contract manufacturing market. Key market players' innovative launches, strategic collaborations, partnerships, and mergers and acquisitions further contribute to market expansion. For instance, in May 2023, Bridgewest Group launched a new contract development and manufacturing organization (CDMO), NovaCina, focused on sterile injectable drug products.

Sterile Injectable Contract Manufacturing Market Key Developments:

  • In July 2023, WuXi STA, a global Contract Research, Development, and Manufacturing Organisation (CRDMO), has launched a first high potency (HP), fully automated sterile injectable manufacturing line at its drug product site in Wuxi City, China.
  • In Aug 2022, American Injectables announced that the company has successfully completed the commissioning and qualification of its newly constructed facility in addition to the completion of Series A financing.
  • In Sept 2022, Aktiv Pharma Group announced the acceptance of its novel glass-free, film-based flexible primary drug container (PDC) technology for sterile injectables named ARCH, into the US Food and Drug Administration (FDA) Emerging Technology Program (ETP).
  • In Aug 2022, American Injectables announced that the company has successfully completed the commissioning and qualification of its newly constructed facility in addition to the completion of Series A financing.    

Sterile Injectable Contract Manufacturing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.50%

Largest Market

North America

Fastest Growing Market

North America
Sterile Injectable Contract Manufacturing Market Dynamics

Focusing on core competencies is a key driver of revenue growth in the sterile injectable contract manufacturing market. Pharmaceutical companies recognize the value of directing their resources toward research, development, regulatory compliance, and marketing, which are central to their strengths. By outsourcing sterile injectable manufacturing to specialized contract manufacturing organizations (CMOs), pharmaceutical companies can streamline operations and allocate their expertise and capital where they have the most impact. The speed-to-market factor is a crucial driver of the sterile injectable contract manufacturing market's growth and success. Collaborating with contract manufacturers can expedite the timeline for product development, regulatory approval, and commercial launch. This is particularly important in the fast-paced pharmaceutical industry were getting products to market quickly can be a competitive advantage.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Sterile Injectable Contract Manufacturing Market Segmentation

By Product Type
  • Small Volume Products
  • Large Volume Products
  • Suspensions
  • Lyophilized Products
  • Others
By Service Type
  • Formulation
  • Analytical Services
  • Packaging
  • Others
By Drug Type
  • Immunoglobulins
  • Cytokines
  • Monoclonal Antibodies
  • Vaccines
  • Insulin
  • Peptide Hormones
  • Antibiotics
  • Others
By Therapeutic Area
  • Diabetes
  • Cancer
  • Infectious Diseases
  • Neurological Diseases
  • Cardiovascular Diseases
  • Musculoskeletal Diseases
  • Others

Frequently Asked Questions

Sterile injections are capturing the market of solid dosage form which may be lucrative for outsourcing market in the forecasted years.

Manufacturing costs in Asia Pacific region is much cheaper than North America and Europe. This is the key opportunity for outsourcing manufacturing process of sterile injectable products.  

Demand for prefilled syringes is growing at a significant rate which will drive the global market. However, the high cost of prefilled syringes may hamper the market growth.

The stringent regulations regarding approval of products are hampering the global market growth.

1.Executive Summary
2.Global Sterile Injectable Contract Manufacturing Market Introduction 
2.1.Global Sterile Injectable Contract Manufacturing Market  - Taxonomy
2.2.Global Sterile Injectable Contract Manufacturing Market  - Definitions
2.2.1. By Type 
2.2.2. By Services Type
2.2.3. By Drug Type
2.2.4. By Therapeutic Area
2.2.5. By Region
3.Global Sterile Injectable Contract Manufacturing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Sterile Injectable Contract Manufacturing Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Sterile Injectable Contract Manufacturing Market  By Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Small Volume Products
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Large Volume Products
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Suspensions
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Lyophilized Products
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Sterile Injectable Contract Manufacturing Market  By Services Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Formulation
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Analytical Services
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Packaging
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Sterile Injectable Contract Manufacturing Market  By Drug Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Immunoglobulins
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Cytokines
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Monoclonal Antibodies
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Vaccines
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Insulin
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Peptide Hormones
7.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
7.7. Antibiotics
7.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.7.3. Market Opportunity Analysis 
7.8. Others
7.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.8.3. Market Opportunity Analysis 
8.Global Sterile Injectable Contract Manufacturing Market  By Therapeutic Area, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Diabetes
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Cancer
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Infectious Diseases
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Neurological Diseases
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Cardiovascular Diseases
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
8.6. Musculoskeletal Diseases
8.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.6.3. Market Opportunity Analysis 
8.7. Others
8.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.7.3. Market Opportunity Analysis 
9.Global Sterile Injectable Contract Manufacturing Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Sterile Injectable Contract Manufacturing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Type  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Small Volume Products
10.1.2.Large Volume Products
10.1.3.Suspensions
10.1.4.Lyophilized Products
10.1.5.Others
10.2.  Services Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Formulation
10.2.2.Analytical Services
10.2.3.Packaging
10.2.4.Others
10.3.  Drug Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Immunoglobulins
10.3.2.Cytokines
10.3.3.Monoclonal Antibodies
10.3.4.Vaccines
10.3.5.Insulin
10.3.6.Peptide Hormones
10.3.7.Antibiotics
10.3.8.Others
10.4.  Therapeutic Area Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Diabetes
10.4.2.Cancer
10.4.3.Infectious Diseases
10.4.4.Neurological Diseases
10.4.5.Cardiovascular Diseases
10.4.6.Musculoskeletal Diseases
10.4.7.Others
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Sterile Injectable Contract Manufacturing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Small Volume Products
11.1.2.Large Volume Products
11.1.3.Suspensions
11.1.4.Lyophilized Products
11.1.5.Others
11.2.  Services Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Formulation
11.2.2.Analytical Services
11.2.3.Packaging
11.2.4.Others
11.3.  Drug Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Immunoglobulins
11.3.2.Cytokines
11.3.3.Monoclonal Antibodies
11.3.4.Vaccines
11.3.5.Insulin
11.3.6.Peptide Hormones
11.3.7.Antibiotics
11.3.8.Others
11.4.  Therapeutic Area Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Diabetes
11.4.2.Cancer
11.4.3.Infectious Diseases
11.4.4.Neurological Diseases
11.4.5.Cardiovascular Diseases
11.4.6.Musculoskeletal Diseases
11.4.7.Others
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Sterile Injectable Contract Manufacturing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Small Volume Products
12.1.2.Large Volume Products
12.1.3.Suspensions
12.1.4.Lyophilized Products
12.1.5.Others
12.2.  Services Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Formulation
12.2.2.Analytical Services
12.2.3.Packaging
12.2.4.Others
12.3.  Drug Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Immunoglobulins
12.3.2.Cytokines
12.3.3.Monoclonal Antibodies
12.3.4.Vaccines
12.3.5.Insulin
12.3.6.Peptide Hormones
12.3.7.Antibiotics
12.3.8.Others
12.4.  Therapeutic Area Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Diabetes
12.4.2.Cancer
12.4.3.Infectious Diseases
12.4.4.Neurological Diseases
12.4.5.Cardiovascular Diseases
12.4.6.Musculoskeletal Diseases
12.4.7.Others
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Sterile Injectable Contract Manufacturing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Small Volume Products
13.1.2.Large Volume Products
13.1.3.Suspensions
13.1.4.Lyophilized Products
13.1.5.Others
13.2.  Services Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Formulation
13.2.2.Analytical Services
13.2.3.Packaging
13.2.4.Others
13.3.  Drug Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Immunoglobulins
13.3.2.Cytokines
13.3.3.Monoclonal Antibodies
13.3.4.Vaccines
13.3.5.Insulin
13.3.6.Peptide Hormones
13.3.7.Antibiotics
13.3.8.Others
13.4.  Therapeutic Area Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Diabetes
13.4.2.Cancer
13.4.3.Infectious Diseases
13.4.4.Neurological Diseases
13.4.5.Cardiovascular Diseases
13.4.6.Musculoskeletal Diseases
13.4.7.Others
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Sterile Injectable Contract Manufacturing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Small Volume Products
14.1.2.Large Volume Products
14.1.3.Suspensions
14.1.4.Lyophilized Products
14.1.5.Others
14.2.  Services Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Formulation
14.2.2.Analytical Services
14.2.3.Packaging
14.2.4.Others
14.3.  Drug Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Immunoglobulins
14.3.2.Cytokines
14.3.3.Monoclonal Antibodies
14.3.4.Vaccines
14.3.5.Insulin
14.3.6.Peptide Hormones
14.3.7.Antibiotics
14.3.8.Others
14.4.  Therapeutic Area Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Diabetes
14.4.2.Cancer
14.4.3.Infectious Diseases
14.4.4.Neurological Diseases
14.4.5.Cardiovascular Diseases
14.4.6.Musculoskeletal Diseases
14.4.7.Others
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Baxter
15.2.2.Catalent, Inc.
15.2.3.Bryllon LLC
15.2.4.Pfizer CentreOne (Pfizer, Inc.)
15.2.5.Vetter Pharma
15.2.6.West Pharmaceutical Services, Inc.
15.2.7.Aenova Group
15.2.8.Fresenius Kabi
15.2.9.Jubilant HollisterStier LLC
15.2.10.Unither Pharmaceuticals
15.2.11.Famar
15.2.12.AbbVie, Inc.
15.2.13.Cipla Inc
15.2.14.NextPharma Technologies
16. Research Methodology 
17. Appendix and Abbreviations 
  • Baxter
  • Catalent, Inc.
  • Bryllon LLC
  • Pfizer CentreOne (Pfizer, Inc.)
  • Vetter Pharma
  • West Pharmaceutical Services, Inc.
  • Recipharm AB
  • Aenova Group
  • Fresenius Kabi
  • Jubilant HollisterStier LLC
  • Unither Pharmaceuticals
  • Famar
  • AbbVie, Inc.
  • Cipla Inc
  • NextPharma Technologies

Adjacent Markets